Search

Diagnostic Value of Serum Thyroglobulin, Diagnostic 131I Whole-body Scan and Neck Ultrasonography for Evaluation of Lymph Node Metastasis and Recurrence of Differentiated Thyroid Cancer

ObjectiveTo compare the diagnostic efficacy of serum thyroglobulin (Tg), diagnostic 131I whole-body scan (D-WBS), neck ultrasound for diagnosing metastasis and recurrence of differentiated thyroid carcinoma (DTC). MethodsFrom May to June 2011, fifty follow-up DTC patients were collected retrospectively 6 months or more after 131I ablation therapy following total-thyroidectomy or near-total thyroidectomy. The diagnostic standard for DTC metastasis and relapse were based on serum Tg, D-WBS, neck ultrasound and chest CT. Diagnostic 2 by 2 table was employed for calculating the sensitivity, specificity, accuracy of the methods. ResultsThe sensitivity, specificity, accuracy, positive predictive value, negative predictive value of TgIMA and D-WBS parallel experiments were 100.0%, 92.9%, 96.0%, 91.7%, and 100.0% respectively. ConclusionTgIMA combined with D-WBS parallel test in diagnosis of DTC metastasis and recurrence has the highest accuracy.

甲状腺功能亢进碘131治疗后迟发性放射性甲状腺炎的治疗护理一例

碘131治疗儿童甲状腺乳头状癌伴颈部淋巴结转移的护理一例

分化型甲状腺癌患者术后碘131治疗的不良反应护理

目的 总结核医学科分化型甲状腺癌术后患者口服碘131（131I）治疗的常见不良反应及处理。 方法 收集2013年7月－2014年6月经131I治疗的分化型甲状腺癌术后患者970例，总结131I治疗过程中出现的不良反应，以及针对各种不良反应给予的相应处理措施。 结果 970例分化型甲状腺癌术后患者均顺利出院，502例出现不良反应，不良反应发生率为5 1.75%。其中头颈部反应258例，消化道反应398例，造血系统反应2例，生殖系统反应1例。在发生不良反应的502例患者中，401例患者出现的不良反应在其出院时均得到有效缓解，53例患者在出院1个月后电话随访中告知不良反应已消失，48例诉症状已逐渐减轻。 结论 131I治疗分化型甲状腺癌可出现一过性的不良反应。对症处理后均可恢复正常。